Study guide
Retinopathy of Prematurity: Screening, Classification and Follow-up
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Retinopathy of Prematurity: Screening, Classification and Follow-up
Key Takeaways Explain This Topic AI
ROP screening uses gestational, postnatal and postmenstrual ages; apply the current national timetable.
Classify each eye by zone, stage, extent and vascular severity, including aggressive disease.
Treatment criteria precede historical threshold disease; borderline disease requires prompt specialist discussion.
Anti-VEGF regression requires prolonged surveillance for persistent avascular retina and delayed reactivation.
Last updated: October 2026
Prematurity creates a surveillance problem
Retinopathy of prematurity (ROP) is disordered retinal vascular development in an incompletely vascularised retina. Premature birth interrupts normal development; oxygen exposure and systemic illness influence a later hypoxic drive to abnormal vascular proliferation. Screening aims to find sight-threatening disease before tractional detachment. An infant may have no externally visible warning sign, so screening eligibility and scheduled follow-up cannot depend on apparent vision or absence of leukocoria.
Distinguish gestational age at birth, postnatal age and postmenstrual age , which combines gestational and postnatal age. Local eligibility varies because neonatal populations and care differ. The UK guideline revised in October 2024 screens infants born before 31 weeks or with birth weight below 1501 g and also recommends considering those born at 31+0 to 31+6 weeks. For birth before 31 weeks, the first examination is in the 31+0–31+6 postmenstrual week or at four completed postnatal weeks, whichever is later. For eligible infants born from 31 weeks, it is in the 36+0–36+6 postmenstrual week or four completed postnatal weeks, whichever is sooner. These are UK rules, not a universal EBO-wide timetable. See the RCPCH 2024 guideline .
Classify each eye completely
The third International Classification, ICROP3 , describes zone, stage, extent and vascular severity, with aggressive disease, regression and reactivation recorded. Zone I is centred on the disc with radius twice the disc-to-fovea distance. Zone II extends to the nasal ora; zone III is the remaining temporal crescent. The most posterior disease determines zone, including a notch into a more posterior zone. Do not label an eye zone III without adequate examination of the nasal retina.
- Stage Finding
- 1 Demarcation line at the vascular–avascular junction
- 2 Elevated ridge
- 3 Extraretinal neovascular proliferation, including flat neovascularisation
- 4A / 4B Partial detachment with fovea attached / detached
- 5 Total detachment, further described by configuration and anterior changes
Plus disease reflects increased vascular dilation and tortuosity; pre-plus lies between normal and plus on a spectrum. ICROP3 emphasises the overall posterior vascular appearance rather than a rigid photographic-quadrant shortcut. Aggressive ROP replaces “aggressive posterior ROP” because rapid aggressive disease is not confined to one posterior location. It may progress without passing neatly through all conventional stages. Record clock-hour extent and the appearance in each eye. The original ICROP3 publication supplies classification rather than a complete treatment protocol.
Referral and treatment
Traditional ETROP type 1 treatment criteria include zone I ROP with plus at any stage, zone I stage 3 without plus, and zone II stage 2 or 3 with plus. Protocols can differ at borderline disease: UK guidance specifically describes zone II stage 2 with plus as requiring treatment consideration or review within a week or less. Aggressive disease and rapid change require prompt discussion with the treating specialist. Do not wait for historical “threshold” clock-hour criteria in an eye meeting contemporary treatment criteria.
Laser treats avascular retina and reduces its angiogenic drive, at the cost of peripheral retinal destruction and potential refractive consequences. Intravitreal anti-VEGF can allow further vascularisation and is particularly useful in selected posterior or aggressive disease, but it introduces uncertainty about systemic exposure and delayed reactivation. Agent, dose and authorisation depend on current national guidance and product information. Do not transfer adult retinal injection doses to a premature infant.
Discuss these trade-offs with parents and neonatologists and arrange appropriate analgesia, monitoring and respiratory support for the chosen procedure. Detachment may require specialist vitreoretinal surgery; prognosis depends on stage and anatomy. The RCOphth treatment guidance should be used alongside screening guidance.
Safe examination and continuity
A dilated binocular indirect examination or validated wide-field imaging pathway must assess the relevant peripheral retina. Imaging can miss peripheral disease, so a screening programme must specify how incomplete views and final assessments are handled. Use age-appropriate mydriatic preparation, comfort measures and cardiorespiratory monitoring. A distressed or unstable infant needs senior coordination, not an unexplained missed examination. Record findings, images when available, the next examination and who owns follow-up.
After anti-VEGF, apparent disappearance of plus or stage 3 does not establish permanent cure. Persistent avascular retina and later reactivation require prolonged surveillance under the treatment protocol. Discharge or transfer between hospitals must include the exact examination plan and contact responsible for arranging it. Parents need clear instructions about the importance of attendance, with practical support if appointments are difficult.
Later childhood assessment addresses myopia, astigmatism, amblyopia, strabismus and possible late retinal complications. A treated infant with attached retinas may still need substantial visual support. In an exam case, state the complete classification, whether referral is urgent, the available treatment options and the surveillance obligation; treatment without follow-up is an incomplete answer.
Sections you finish are checked off in the contents.
- Up Next
- Childhood Cataract, Leukocoria and Congenital Glaucoma
- Continue learning